Clinical Trial

Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study is focused on evaluation of the effectiveness of the Admittance Pulmonary Artery Catheter (PAC) system for assessing the right ventricular (RV) function in patients with tricuspid regurgitation (TR) prior to tricuspid valve intervention.
Trial Details
NCT Number NCT07500025
Lead Sponsor Feldman Cardiology, PLLC
Conditions Tricuspid Regurgitation (TR)
Enrollment 8 participants
Start Date 2027-07-10
Primary Completion 2028-07-10 (estimated)
Study Completion 2028-07-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-30